Must-See: Jim Cramer’s 10 Best Stock Picks for Investors Right Now
In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy might lead the Federal Reserve to ease its policies.
Abbvie Inc. (ABBV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,617,800 | $449,005,056 | +5% | 0.09% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 1,420,280 | $243,606,426 | -41% | 0.45% |
| 3. | AQR Capital Management Cliff Asness | 1,404,428 | $237,811,874 | -9% | 0.36% |
| 4. | Diamond Hill Capital Ric Dillon | 1,356,764 | $232,712,161 | +2% | 0.99% |
| 5. | Renaissance Technologies Jim Simons | 1,304,671 | $223,777,170 | +16% | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $186.52 | 66,500 | 446,599 | 2024-08-05 | Filing | ||
| $175.00 | 282,845 | 513,099 | 2024-07-17 | Filing | ||
| $176.30 | 21,082 | 55,903 | 2024-03-20 | Filing | ||
| $178.69 | 27,740 | 60,941 | 2024-03-18 | Filing | ||
| $179.03 | 5,099 | 88,681 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 160,398,281 | $24,856,921,606 | 0.54% | |
| 2. | 143,182,709 | $22,189,024,406 | 0.56% | |
| 3. | 78,200,866 | $12,118,788,204 | 0.58% | |
| 4. | 51,818,311 | $8,030,283,833 | 0.85% | |
| 5. | 44,988,183 | $6,971,795,864 | 1.56% |
News See All
10 Best Big-Name Stocks to Buy Right Now According to Short Sellers
In early April 2024, Goldman Sachs Inc.’s data revealed that short selling on individual US-listed stocks was at the highest level in 6 months, and the most targeted sectors were technology, telecom...
10 Best Cancer Stocks To Buy Now
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2023...
14 Best 52-Week High Stocks to Buy According to Short Sellers
The U.S. stock market has been on a roll, with major indices clocking double-digit gains even with the U.S. economy showing signs of weakness.
AbbVie Inc. (NYSE:ABBV) Q2 2024 Earnings Call Transcript
Operator: Good morning and thank you for standing by. Welcome to the AbbVie Second Quarter 2024 Earnings Conference Call.
AbbVie (ABBV) Fell as its Arthritis Drug Went Off Patent
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
50 Largest Companies in Every State in the US
The United States holds the title of the largest economy in the world, according to the IMF in 2024 the United States had a GDP of approximately $28.78 trillion, a GDP per capita of around $85,370, and...
25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
10 Best Dividend Aristocrat Stocks To Buy Now
Dividend growth investing strategy is in the spotlight these days as investors scramble to offset market risks in a higher-for-longer environment where interest rates aren’t expected to come down anytime...
15 Best S&P 500 Dividend Stocks To Buy Now
In this article, we discuss 15 best S&P 500 dividend stocks to buy now.